A hypothetical respiratory syncytial virus (RSV) vaccine may be cost effective in the elderly Dutch population who are at high risk of contracting RSV infections. Results of the modelling study showed that it would not be cost effective to vaccinate the entire Dutch population aged ≥ 60 ...
Respiratory syncytial virus (RSV) infections are one of the leading causes of lower respiratory tract disease among adults aged ≥60 years in Europe. This study aims to assess the potential public health impact of the RSVPreF3 OA adjuvanted vaccine, the first approved preventive intervention for ...
To understand the potential impact of RSV vaccinations, researchers created a model to assess the cost-effectiveness of vaccine programs in different age groups with different medical risks. Most existing cost-effectiveness studies have focused on adults aged 60 and older, but in this study, research...
Hypothetical RSV vaccine cost effective in the elderly Journal PharmacoEconomics & Outcomes News Volume 252, Issue 1 , p 5 Cover Date 2000-03-01 DOI 10.1007/BF03266907 Print ISSN 1173-5503 Online ISSN 1179-2043 Publisher Springer International Publishing Additional Links Register for Journal Update...
difficulty in the differentiation between recent and past infections, and cost-effectiveness, it is not possible and rational to perform screening of donated... G Karimi,A Mardani,M Zadsar - 《Iranian Journal of Parasitology》 被引量: 9发表: 2016年 Vaccine-therapy in hepatitis B virus carriers...
Recent Content Q&A: The Importance of ASHP’s 2025 Pharmacy Forecast Vaccine Hesitancy, Access Growing Concerns Among Patients With Chronic Diseases Majority of Online GLP-1 Advertising Misinformed Potential Consumers National Support for Medication Abortion Access Increased Since Dobbs Decision View More ...
humanised mouse monoclonal antibody neutralizes the RSV F protein; Results of a study into its safety and effectiveness; Cost; Comparison to other ... M Sharland,A Bedford-Russell - Bmj 被引量: 51发表: 2001年 Using PHMB antimicrobial to prevent wound infection Post-operative wound infections ...
Most currently available vaccines, particularly live vaccines, require the cold chain, as vaccine efficacy can be significantly hampered if they are not stored in a temperature range of 2–8 °C at all times. This necessity places a tremendous financi
What Older Adults Need to Know About the Flu Vaccine Written By Christina Aungst, PharmDUpdated on Oct 2, 2024 Guide to Shingrix (Shingles Vaccine): Side Effects, Cost, Schedule, and More Written By Mandy Armitage, MDUpdated on Oct 2, 2024 ...
In 2011, intranasally administered live attenuated influenza vaccine (LAIV) was approved in the EU for prophylaxis of seasonal influenza in 2–17-year-old children. Our objective was to estimate the potential epidemiological impact and cost-effectiveness of an LAIV-based extension of the influenza ...